L’Oréal strengthens its position in microbiome research to break new ground in cosmetic innovation with the acquisition of Lactobio, a probiotic and microbiome research company based in Copenhagen. According to the company, the acquisition opens up new scientific opportunities, including leveraging Lactobio’s microbiome expertise and significant IP portfolio to develop safe and effective cosmetics solutions using live bacteria.
Lactobio was founded in 2017 by Drs. Søren Kjærulff and Charlotte Vedel, who developed a unique, proprietary microbiome discovery platform and screening method to select the most effective and safe strains. These probiotics, created from a large biobank of lactobacilli bacteria, will be used in the development of topical formulations containing live bacteria, inspired by nature and aimed to provide multiple benefits to skin and hair.
As Anne Colonna, Global Head of Advanced Research of the L’Oréal Group stated “the integration of Lactobio into L’Oréal’s Advanced Research is highly complementary: L’Oréal’s strong scientific knowledge and technological progress combined with the best Lactobio’s formulations in the category using living organisms will greatly enhance and accelerate beauty-focused microbiome research. We will develop a new generation of cosmetics that will use leading innovations in the formulation process to deliver precision science, probiotic and metabiotic products with new levels of performance.”
